OvaScience, Inc. OVAS Securities Lawsuit

Company:	OvaScience, Inc.
Ticker Symbol:	OVAS
Class Period:	Feb-25-13 to Sep-10-13
Date Filed:	Jul-1-14
Lead Plaintiff Deadline:	Aug-30-14
Court:	District of Massachusetts
Allegations:

Boston, MA: A securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of all purchasers of the securities of OvaScience, Inc. ("OvaScience" or the "Company") (NASDAQ:OVAS) between February 25, 2013 and September 10, 2013, inclusive (the "Class Period").

OvaScience is engaged in the discovery, development and commercialization of new treatments for infertility. The Company's product AUGMENT is an assisted reproductive technology which complements the existing standard of practice for an in vitro fertilization cycle. The Complaint alleges that the Company misrepresented or failed to disclose material information concerning the clinical development of AUGMENT and regulatory concerns raised by the Food and Drug Administration that could potentially threaten or delay FDA approval of AUGMENT. On September 10, 2013, OvaScience disclosed that it was suspending enrollment of the AUGMENT clinical trial in the United States, after the Company received a letter from the FDA questioning whether AUGMENT qualified for reduced regulatory oversight and advising the Company to file an Investigational New Drug application.

If you acquired the securities of the defendants during the Class Period you may, no later than the Lead Plaintiff Deadline shown above, request that the Court appoint you as lead plaintiff through counsel of your choice. You may also choose to remain an absent class member. A lead plaintiff must meet certain requirements.

OvaScience, Inc. OVAS Securities Fraud Legal Help

If you have suffered from financial losses, you may qualify for damages or remedies that may be awarded in a possible OvaScience, Inc. securities class action lawsuit. Please click the link below to submit your complaint for a free evaluation.